Richard D. Cherney
Director/Board Member at Benvest Holdings Ltd.
Richard D. Cherney active positions
Companies | Position | Start | End |
---|---|---|---|
Davies Ward Phillips & Vineberg LLP
Davies Ward Phillips & Vineberg LLP Miscellaneous Commercial ServicesCommercial Services Davies Ward Phillips & Vineberg LLP provides legal services. It offers services to industries, commercial companies and financial institutions. The company's clients include government, regulatory bodies, charitable organizations, international agencies, educational institutions, individuals and trusts & estates. It was founded in February 2002 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 31/12/1984 | - |
Benvest Holdings Ltd. | Director/Board Member | - | - |
eStruxture Data Centers, Inc.
eStruxture Data Centers, Inc. Financial ConglomeratesFinance eStruxture Data Centers, Inc. engages in the provision of data services. It offers colocation, cloud, network, virtual servers, managed hosting, storage, backup, and disaster recovery. The company is headquartered in Montr?al, Canada. | Director/Board Member | - | - |
MacKinnon, Bennett & Co., Inc.
MacKinnon, Bennett & Co., Inc. Investment ManagersFinance MacKinnon, Bennett & Co., Inc. (MKB) is an independent private equity firm founded in 2007 by Kenneth MacKinnon and William John Bennett. The firm is headquartered in Montreal, Canada. | Director/Board Member | - | - |
Addénergie Technologies, Inc.
Addénergie Technologies, Inc. Wholesale DistributorsDistribution Services Addénergie Technologies, Inc. operates electric vehicle charging stations. It develops, manufactures and operates charging solutions for all market segments such as the public sector, employers, multi-residential, fleets and residential. The company was founded by Louis Tremblay in 2009 and is headquartered in Québec, Canada. | Director/Board Member | 13/03/2022 | - |
ExCellThera, Inc.
ExCellThera, Inc. BiotechnologyHealth Technology ExCellThera, Inc. is a world leader in blood stem cell expansion and rejuvenation. The private company is based in Montréal, Canada. The Canadian company's proprietary molecule, UM171, is the standard for hematopoietic stem cell expansion in cell and gene therapy. UM171 has a first-in-class mechanism of action that expands and rejuvenates HSCs, and counteracts exhaustion from culture and gene modification, which are important limitations in cell and gene therapies. ExCellThera has developed commercial GMP grade UM171, which can be integrated into the manufacturing process of various cell and gene therapy products as a reagent and is supported by a Type II Drug Master File (DMF) filed with the FDA. ExCellThera was founded in 2013 by Peter Zandstra and Guy Sauvageau. Guy Sauvageau has been the CEO since 2013. | Director/Board Member | - | - |
Career history of Richard D. Cherney
Former positions of Richard D. Cherney
Companies | Position | Start | End |
---|---|---|---|
KANE BIOTECH INC. | Director/Board Member | 28/06/2011 | 07/10/2014 |
Independent Dir/Board Member | 28/06/2011 | 07/10/2014 | |
LE CHÂTEAU INC. | Director/Board Member | 31/12/2004 | 07/07/2011 |
Benvest New Look Income Fund
Benvest New Look Income Fund Investment Trusts/Mutual FundsMiscellaneous Benvest New Look Income Fund provides eye care products and services and merchant banking services. It operates through two segments namely Eye Care and Merchant Banking. It operates in its optical business through Lunetterie New Look International, Inc. in Canada. The products of the Group include opthalmic frames, lenses and related services. It was founded in 2005 and is headquartered in Montreal, Canada. | Director/Board Member | 30/04/2005 | 03/03/2010 |
Corporate Secretary | 30/04/2005 | 03/03/2010 | |
░░░ ░░░░ ░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░ ░░░░ ░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Richard D. Cherney
Concordia University | Undergraduate Degree |
McGill University | Graduate Degree |
Statistics
International
Canada | 15 |
Operational
Director/Board Member | 10 |
Corporate Secretary | 3 |
Independent Dir/Board Member | 2 |
Sectoral
Finance | 4 |
Commercial Services | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
KANE BIOTECH INC. | Commercial Services |
Private companies | 11 |
---|---|
Le Château, Inc.
Le Château, Inc. Apparel/Footwear RetailRetail Trade Le Château, Inc. operates as a Canadian retailing brand. It engages in the retail of apparel, accessories and footwear. The firm markets its products under the brand name Le Château, which is designed and developed within its vertically integrated operations. The company was founded by Herschel H. Segal on April 5, 1987 and is headquartered in Mount-Royal, Canada. | Retail Trade |
Davies Ward Phillips & Vineberg LLP
Davies Ward Phillips & Vineberg LLP Miscellaneous Commercial ServicesCommercial Services Davies Ward Phillips & Vineberg LLP provides legal services. It offers services to industries, commercial companies and financial institutions. The company's clients include government, regulatory bodies, charitable organizations, international agencies, educational institutions, individuals and trusts & estates. It was founded in February 2002 and is headquartered in Toronto, Canada. | Commercial Services |
Benvest New Look Income Fund
Benvest New Look Income Fund Investment Trusts/Mutual FundsMiscellaneous Benvest New Look Income Fund provides eye care products and services and merchant banking services. It operates through two segments namely Eye Care and Merchant Banking. It operates in its optical business through Lunetterie New Look International, Inc. in Canada. The products of the Group include opthalmic frames, lenses and related services. It was founded in 2005 and is headquartered in Montreal, Canada. | Miscellaneous |
New Look Eyewear, Inc. /Old/ | |
Benvest Capital, Inc. | Finance |
New Look Vision Group, Inc.
New Look Vision Group, Inc. Medical DistributorsDistribution Services New Look Vision Group, Inc. engages in the eye care retail activities. Its categories of optical products include prescription and non-prescription eyewear; contact lenses; sunglasses, protective eyewear, and reading glasses; and accessories. The company was founded in 1986 and is headquartered in Montréal, Canada. | Distribution Services |
Benvest Holdings Ltd. | |
eStruxture Data Centers, Inc.
eStruxture Data Centers, Inc. Financial ConglomeratesFinance eStruxture Data Centers, Inc. engages in the provision of data services. It offers colocation, cloud, network, virtual servers, managed hosting, storage, backup, and disaster recovery. The company is headquartered in Montr?al, Canada. | Finance |
MacKinnon, Bennett & Co., Inc.
MacKinnon, Bennett & Co., Inc. Investment ManagersFinance MacKinnon, Bennett & Co., Inc. (MKB) is an independent private equity firm founded in 2007 by Kenneth MacKinnon and William John Bennett. The firm is headquartered in Montreal, Canada. | Finance |
Addénergie Technologies, Inc.
Addénergie Technologies, Inc. Wholesale DistributorsDistribution Services Addénergie Technologies, Inc. operates electric vehicle charging stations. It develops, manufactures and operates charging solutions for all market segments such as the public sector, employers, multi-residential, fleets and residential. The company was founded by Louis Tremblay in 2009 and is headquartered in Québec, Canada. | Distribution Services |
ExCellThera, Inc.
ExCellThera, Inc. BiotechnologyHealth Technology ExCellThera, Inc. is a world leader in blood stem cell expansion and rejuvenation. The private company is based in Montréal, Canada. The Canadian company's proprietary molecule, UM171, is the standard for hematopoietic stem cell expansion in cell and gene therapy. UM171 has a first-in-class mechanism of action that expands and rejuvenates HSCs, and counteracts exhaustion from culture and gene modification, which are important limitations in cell and gene therapies. ExCellThera has developed commercial GMP grade UM171, which can be integrated into the manufacturing process of various cell and gene therapy products as a reagent and is supported by a Type II Drug Master File (DMF) filed with the FDA. ExCellThera was founded in 2013 by Peter Zandstra and Guy Sauvageau. Guy Sauvageau has been the CEO since 2013. | Health Technology |
- Stock Market
- Insiders
- Richard D. Cherney
- Experience